|Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer|
BIG 1-98 Collaborative Group
New England Journal of Medicine 361 (8), 766-776, 2009
|Progesterone receptor modulates ERα action in breast cancer|
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
|Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy …|
G Viale, MM Regan, E Maiorano, MG Mastropasqua, P Dell'Orto, ...
Journal of Clinical Oncology 25 (25), 3846-3852, 2007
|Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …|
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
|Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial|
J Cuzick, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, JF Forbes, ...
The lancet oncology 16 (1), 67-75, 2015
|Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer|
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
|Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …|
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
|Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience|
G Berclaz, S Li, KN Price, AS Coates, M Castiglione-Gertsch, ...
Annals of Oncology 15 (6), 875-884, 2004
|Androgens induce divergent proliferative responses in human breast cancer cell lines|
SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ...
The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995
|Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII|
A Wallgren, M Bonetti, RD Gelber, A Goldhirsch, M Castiglione-Gertsch, ...
Journal of Clinical Oncology 21 (7), 1205-1213, 2003
|Breast and prostate cancer: more similar than different|
GP Risbridger, ID Davis, SN Birrell, WD Tilley
Nature Reviews Cancer 10 (3), 205-212, 2010
|Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial|
D Crivellari, Z Sun, AS Coates, KN Price, B Thürlimann, H Mouridsen, ...
Journal of clinical oncology 26 (12), 1972-1979, 2008
|Role of the androgen receptor in human breast cancer|
SN Birrell, RE Hall, WD Tilley
Journal of mammary gland biology and neoplasia 3 (1), 95-103, 1998
|Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial|
M Rabaglio, Z Sun, KN Price, M Castiglione-Gertsch, H Hawle, ...
Annals of oncology 20 (9), 1489-1498, 2009
|Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells|
JM Bentel, SN Birrell, MA Pickering, DJ Holds, DJ Horsfall, WD Tilley
Molecular and cellular endocrinology 154 (1-2), 11-20, 1999
|BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive …|
BJ Thurlimann, A Keshaviah, H Mouridsen, L Mauriac, JF Forbes, ...
Journal of Clinical Oncology 23 (16_suppl), 511-511, 2005
|Swipe imager with multiple sensing arrays|
L Hamid, SN Ashdown
US Patent 7,043,061, 2006
|Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer|
SN Birrell, LM Butler, JM Harris, G Buchanan, WD Tilley
The FASEB Journal 21 (10), 2285-2293, 2007
|MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression|
RE Hall, SN Birrell, WD Tilley, RL Sutherland
European journal of cancer 30 (4), 484-490, 1994
|Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.|
SN Birrell, DM Roder, DJ Horsfall, JM Bentel, WD Tilley
Journal of clinical oncology 13 (7), 1572-1577, 1995